Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project

Rekrutierend

NCT-Nummer:
NCT02613637

Studienbeginn:
Mai 2014

Letztes Update:
24.02.2017

Wirkstoff:
-

Indikation (Clinical Trials):
Lung Neoplasms

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
University of Ulm

Collaborator:
-

Studienleiter

Lars Bullinger, MD
Principal Investigator
University Hospital of Ulm

Kontakt

Lars Bullinger, MD
Kontakt:
Phone: +4973150045900
E-Mail: Lars.Bullinger@uniklinik-ulm.de» Kontaktdaten anzeigen

Gerlinde Schmidtke-Schrezenmeier, MD

Studienlocations
(3 von 3)

Klinikum Esslingen GmbH
Esslingen
(Baden-Württemberg)
GermanyRekrutierend» Google-Maps

Pneumologie, Internistische Intensivmedizin, Beatmungsmedizin und Allgemeine Innere Medizin, Krankenhaus vom Roten Kreuz Bad Cannstatt GmbH
Stuttgart
(Baden-Württemberg)
GermanyRekrutierend» Google-Maps

Leberkrebszentrum Universitätsklinikum Ulm
Albert-Einstein-Allee 23
89081 Ulm
DeutschlandRekrutierend» Google-Maps

Studien-Informationen

Brief Summary:

Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly

Diagnosed or Existent Lung Cancer

The LuCa Biology and Outcome (BiO)-Project

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Patients with suspected diagnosis of lung cancer, or previously diagnosed lung cancer

- Age ≥ 18 years. There is no upper age limit.

Exclusion Criteria:

- Severe neurological or psychiatric disorder interfering with ability to give an

informed consent

- No consent for registration, storage and processing of the individual disease

characteristics and course as well as information of the family physician about study

participation

- No consent for biobanking of patient's biological specimens and performance of

analyses on stored material.

Studien-Rationale

Primary outcome:

1. Overall Survival (Time Frame - maximally 10 years)

Geprüfte Regime

Registry

Quelle: ClinicalTrials.gov